Analysis of Key Factors Associated with Response to Salvage ...
High-dose methotrexate (HD-MTX) rechallenge is generally used in recurrent PCNSL, especially for patients who have achieved a response after initial methotrexate (MTX) treatment. However, the …
(PDF) Analysis of Key Factors Associated with Response to ...
Sep 17, 2022 · High-dose methotrexate (HD-MTX) rechallenge is generally used in recurrent PCNSL, especially for patients who have achieved a response after initial methotrexate (MTX) treatment. …
Treatment of methotrexate-refractory primary central nervous ...
May 14, 2024 · To the Editor,Methotrexate (MTX)-refractory primary central nervous system lymphoma (PCNSL) is associated with poor outcomes. We report the response rates and survival to salvage …
Methotrexate (MTX) rechallenge for recurrent primary CNS ...
May 20, 2011 · However, because MTX is much more active than other agents in PCNSL, a MTX re-challenge has been proposed as a salvage strategy for recurrent disease. In this study, we report our …
We reviewed 39 patients with histologically confirmed PCNSL who responded to methotrexate at initial diagnosis, expe-rienced disease relapse and received methotrexate re-challenge.
Synapse - Methotrexate re-challenge for recurrent primary ...
Methotrexate re-challenge for recurrent primary central nervous system lymphoma Journal Article
Methotrexate Re-Challenge for Recurrent Primary Central ...
In this study, we report our experience with MTX re-challenge in recurrent PCNSL. This retrospective study was approved by the Memorial Sloan-Kettering Cancer Center (MSKCC) Institutional Review …